Convocatoria de manifestaciones de interés para formar parte del Consejo Directivo del IDPC

En el año de nuestro décimo aniversario, el IDPC solicita ‘manifestaciones de interés’ de personas que deseen unirse a nuestro Consejo Directivo. La solicitud se puede enviar hasta el viernes 20 de mayo. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

In the year of our 10th anniversary the International Drug Policy Consortium (IDPC) is seeking ‘expressions of interest’ from individuals to join our Board of Directors. These are voluntary, non-executive positions. We are seeking to recruit two to three new Board members to join us from July 2016. As part of this recruitment process, we are looking to ensure robust succession planning for the positions of Chair and Vice Chair.

IDPC is a global network of over 140 civil society organisations from over 60 countries. We come together to promote objective and open debate on the effectiveness, direction and content of drug policies at the national and international level, and we support evidence-based policies that are effective at reducing drug-related harm. Our advocacy positions are based five core policy principles that prioritise human rights, civil society engagement and reducing the harmful consequences of the illicit drug market, rather than on reducing its scale.

The Board is responsible for the oversight of finances, management and performance of IDPC’s small but dynamic secretariat (based in London and Bangkok). The IDPC secretariat is a UK-based non-profit company limited by guarantee and the Board of Directors retain the financial and legal liability as per our Articles of Association. The Board is supported by a Members’ Advisory Council made up of representatives from the network.

In return for these responsibilities, new Directors would be joining the Board of a highly visible, diverse and growing network with a motivated, effective and committed staff team at the secretariat. IDPC has developed strong financial and administrative systems and processes since it became an independent legal entity in 2011. New Board members will be instrumental in further supporting IDPC as it moves into its next stage of organisational maturity and delivers on the new 5-year strategy that runs to December 2020.

The Board meets quarterly, with three out of four meetings being held by conference call and one annual face-to-face meeting which also serves as the Annual General Meeting. All meetings and documentation are in English only. Successful applicants will be expected to attend the next face-to-face Board meeting in London from the 6th to 8th July 2016. Meetings of the Directors, and all documentation and communication, are in English. Directors need to be available for the annual two-day face-to-face meeting each year in London. Good telephone and internet access is essential. Directors are also expected to be available to provide advice and comments between meetings. Board members will be appointed for one three-year term, with the ability to renew for one further three-year term.

We are particularly seeking individuals with the following skills and experience:

• Experience of advocacy and/or campaigning work
• Experience of advocacy engagement towards governmental and/or multi-lateral agencies
• Successful track record of fundraising and ability to support resource mobilisation for IDPC
• Experience from outside of the drug policy ‘field’, ideally in a related field such as health, human rights, development
• Experience of working within government settings
• Experience of financial oversight and management of organisations like IDPC
• Experience of human resource oversight and management

Interested individuals should send a CV and a short cover letter outlining why they are interested in joining the Board of IDPC, and highlighting their relevant skills and experience for the Board position. These expressions of interest must be sent to Juan Fernandez (jfernandez@idpc.net) by no later than Friday 20th May 2016.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: NSCC website